Latest Cholangiocarcinoma Stories
Scientists have confirmed that metabolic syndrome, a constellation of conditions that increases the risk of heart disease and diabetes, may also increase the risk of the two most common types of liver cancer.
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver CongressTM 2011.
The Cholangiocarcinoma Foundation has designated February as cholangiocarcinoma awareness month. (PRWEB) February 1, 2011 The Cholangiocarcinoma Foundation has designated February as cholangiocarcinoma awareness month.
A recent study of 110 patients suffering from malignant pleural mesothelioma has found that although single modality therapy has traditionally been the most common treatment approach, it has largely failed to treat this aggressive cancer, leading to a continued poor prognosis.
Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients.
Adding chemotherapy to radiation therapy for muscle invasive bladder cancer allows 67 percent of people to be free of disease in their bladders two years after treatment.
Gastric cancer is a major cause of cancer deaths in the world.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness.
Pancreatic cancer is one of the most challenging tumors to treat.
Intrahepatic cholangiocarcinoma (ICC) is a cancer of the bile duct in the liver.
The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...